Company / Accounts Receivable
AdaptHealth Corp. Accounts Receivable History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$370.9M
FY2025
5-year range
$359.1M / $408.0M
FY2021-FY2025
Trend
-9.1%
vs FY2024
Sector context
#54 of 138
Health Care
What the data says
At $371M, AdaptHealth Corp.'s accounts receivable ranks #54 of 138 in the Health Care sector. Accounts Receivable has fluctuated over the past 8 years, ranging from $53M in FY2018 to $408M in FY2024.
Based on SEC 10-K filings.
$371M in FY2025 with a 5-year CAGR of +16.7%.
Declined from $389M to $371M over the past 2 years.
Health Care sector context is included.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- +1.1%
- 5-Year CAGR
- +16.7%
- 10-Year CAGR
- -
Sector benchmark
#54 of 138 in Health CareTop 39% of 138This company $370.9M Sector average $1.3B
▼
-71.9% below sector average
Key checks
Key Insights
- 5-year CAGR of +16.7%, indicating consistent growth.
- In FY2025, accounts receivable decreased 9.1% year-over-year.
- Ranks #54 out of 138 companies in the Health Care sector.
- Peak accounts receivable was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score 0.92 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $370.9M | -9.1% |
| FY2024 | $408.0M | +4.9% |
| FY2023 | $388.9M | +8.3% |
| FY2022 | $359.1M | -0.2% |
| FY2021 | $359.9M | +110.4% |
| FY2020 | $171.1M | +117.6% |
| FY2019 | $78.6M | +48.3% |
| FY2018 | $53.0M | - |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026